Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib dose escalation in metastatic renal cell carcinoma
NCT00618982Phase 2Completed
- Sponsor
- Bayer
- Start
- Feb 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of sorafenib in renal cell carcinoma (RCC), sponsored by Bayer. Started Feb 2008; status: completed.
02
Drugs
sorafenib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00618982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00618982.